SCHEMBL9680177

SCHEMBL9680177

Cc1cccc(N)c1-c1cccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.56
ALDH1A1 P00352 6/20 0.54
HPGD P15428 4/20 0.54
HSD17B10 Q99714 4/20 0.54
CYP3A4 P08684 3/20 0.54
TSHR P16473 3/20 0.54
CYP2A6 P11509 3/20 0.54
KEAP1 Q14145 1/20 0.54
TDP1 Q9NUW8 3/20 0.45
DPP4 P27487 1/20 0.45
KDM4E B2RXH2 3/20 0.43
CD44 P16070 1/20 0.43
CYP1A2 P05177 3/20 0.43
ADORA2A P29274 2/20 0.41
PTPRC P08575 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132842 0.88 CYP2A6 (0.62) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL29801671 0.88 CYP2A6 (0.62) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL15812930 0.84 ALDH1A1 (0.58) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL5709171 0.84 DHFR (0.51) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL788001 0.84 ALDH1A1 (0.56) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL9678804 0.81 CYP3A4 (0.54) ALDH1A1HSD17B10CYP3A4TSHRTDP1
SCHEMBL3794845 0.81 ALDH1A1 (0.55) ALDH1A1HSD17B10CYP3A4TSHRTDP1
SCHEMBL21110891 0.81 DHFR (0.49) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL4915508 0.80 ALDH1A1 (0.52) DHFRALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL29418125 0.80 ALDH1A1 (0.52) DHFRALDH1A1HPGDHSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed
US-4950414-A MIXTURE OF POLYISOBUTENE AND PHOSPHETANE ADDITIVE UK-MINERALOLWERKE WENZEL & WEIDMANN, GMBH (DE) 1990-08-21 US disclosed